News for ALX Oncology Holdings Inc. (ALXO)

PR NewswireVANCOUVER, BC, March 8, 2025 USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, March 8, 2025 /PRNewswire/

ALX Oncology Holdings Inc. (ALXO, Financials) saw its stock price fall 15.8% to $1.52 as of 2:32 p.m. GMT-5 on Thursday, despite announcing positive updated res

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer S

Here is how ALX Oncology Holdings Inc. (ALXO) and Ginkgo Bioworks Holdings, Inc. (DNA) have performed compared to their sector so far this year.

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (”œALX Oncology”) ( ALXO), a clinical-stage biotechnology compan

Alx oncology interim CFO Pinto sells $2,253 in stock

**media[490412]**

Webcast on December 17 at 8:00 AM EST to feature ALX Oncology leadership and study principal investigator Alberto J. Montero, MD, MBA SOUTH SAN FRANCISCO, Cali

**media[488557]**

On December 2, 2024, Rekha Hemrajani, a Director at ALX Oncology Holdings Inc (ALXO), purchased 30,000 shares of the company. Following this transaction, the in

U.S. stocks traded lower toward the end of trading, with the Dow Jones index dipping more than 650 points on Thursday. The Dow traded down 1.61% to 40,184.39 w...

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping more than 500 points on Thursday. The Dow traded down 1.26% to 40,327.48 whil...

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 1% on Thursday. The Dow traded up 0.03% to 40,853.73 while the NASDAQ r...

Shares of Carvana Co. CVNA rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results. Carvana...

Massachusetts -based Bone Biologics Corporation (BBLG) is up over 61 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

With a track record of successfully taking companies public, Pietzke joins the clean energy innovator for its next stage of business growth and...

Roche (OTC: RHHBY) announced that the European Commission has granted marketing authorization to the subcutaneous formulation of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) drug Ocrevus (ocrelizumab).

AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of Skyrizi (risankizumab) in the EU to treat adults with moderately to severely active ulcerative colitis (UC).